Dave Asprey's Peptide Stack

About this video

Reacting to Dave Asprey’s account of rapidly gaining a large amount of supposed muscle while using multiple SARMs at once, Gillett and O’Hara are openly sceptical. They suggest fluid retention and measurement artefacts are more plausible explanations than permanent contractile tissue, note strength did not appear to match the claim, and speculate about product mislabelling in unregulated markets without asserting what Asprey actually took. They credit Asprey for discussing his use publicly, but argue stacking several experimental androgen-like agents resembles a steroid cycle with liver and other risks. Counterintuitively, they argue SARMs are more directly muscle-building than current peptides, yet bioidentical testosterone would usually have a better risk profile.

Key takeaways

• Rapid scale and bioimpedance changes should not be equated with new muscle tissue
• Public disclosure by influencers enables critique but does not validate a protocol
• Stacking multiple experimental agents multiplies unknown risks, the hosts argue
• Peptides are framed as recovery-supporting at best, not strongly anabolic
• Avoiding bioidentical testosterone for stigma reasons can lead people to riskier substitutes

Episode details: published April 3, 2026 · 1.5K views · 9:02 long. Summary written by Self Growth Videos from the episode itself. The hormone, metabolic and peptide concepts described are Dr. Kyle Gillett’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Gillett Health is a clinical practice that treats these conditions.

← Previous: Are GLP1’s getting banned? · Next: Are Testicular Fillers Real? TRT Side Effects, Finasteride Myths, & AI in Surgery w/ Dr. Fantus →

All Dr. Kyle Gillett videos · Dr. Kyle Gillett profile · Gillett Health (official site)